Ralf-Dieter Hofheinz Selected Research

Ralf-Dieter Hofheinz Research Topics

Disease

55	Neoplasms (Cancer) 04/2024 - 01/2005
32	Rectal Neoplasms (Rectal Cancer) 02/2024 - 03/2005
20	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2005
15	Adenocarcinoma 11/2023 - 01/2009
11	Stomach Neoplasms (Stomach Cancer) 01/2021 - 03/2005
8	Disease Progression 11/2023 - 06/2008
8	Neoplasm Metastasis (Metastasis) 12/2017 - 10/2006
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2016 - 01/2009
6	Diarrhea 11/2022 - 01/2005
5	Breast Neoplasms (Breast Cancer) 06/2022 - 08/2005
5	Squamous Cell Carcinoma of Head and Neck 08/2014 - 04/2011
4	Carcinoma (Carcinomatosis) 01/2021 - 12/2010
4	Exanthema (Rash) 12/2017 - 08/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2008
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 01/2021
3	Hypertension (High Blood Pressure) 01/2023 - 01/2015
3	Anorexia 01/2023 - 07/2009
3	Leukopenia 11/2022 - 01/2005
3	Fatigue 01/2015 - 01/2005
3	Nausea 01/2013 - 01/2005
2	Microsatellite Instability 02/2024 - 01/2021
2	Pathologic Complete Response 11/2022 - 12/2019
2	Glioma (Gliomas) 01/2022 - 12/2018
2	Melanoma (Melanoma, Malignant) 12/2021 - 08/2015
2	Pain (Aches) 01/2021 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 03/2018 - 01/2017
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2018 - 06/2017
2	Esophageal Neoplasms (Esophageal Cancer) 12/2015 - 03/2014
2	Hand-Foot Syndrome 08/2015 - 01/2005
2	Proctitis 06/2012 - 08/2009
2	Vomiting 08/2009 - 01/2005
2	Anus Neoplasms (Anal Cancer) 01/2009 - 05/2008
1	Hyperthermia 10/2023
1	Infections 01/2023

Drug/Important Bio-Agent (IBA)

22	Fluorouracil (Carac)FDA LinkGeneric 11/2023 - 01/2005
19	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 03/2004
18	Capecitabine (Xeloda)FDA Link 05/2022 - 01/2005
14	Leucovorin (Folinic Acid)FDA Link 11/2023 - 01/2005
11	ErbB Receptors (EGF Receptor)IBA 11/2022 - 01/2009
11	Cetuximab (Erbitux)FDA Link 01/2021 - 12/2006
11	Irinotecan (Camptosar)FDA LinkGeneric 09/2019 - 01/2005
10	Trastuzumab (Herceptin)FDA Link 01/2023 - 02/2013
9	Docetaxel (Taxotere)FDA Link 11/2023 - 12/2010
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2009
5	PlatinumIBA 01/2020 - 05/2013
4	Mitomycin (Mitomycin-C)FDA LinkGeneric 05/2014 - 03/2005
3	RamucirumabIBA 01/2023 - 06/2015
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2015
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 04/2011
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 07/2009
3	Panitumumab (Vectibix)FDA Link 09/2019 - 11/2016
3	CateninsIBA 04/2016 - 06/2013
3	Phosphotransferases (Kinase)IBA 01/2016 - 09/2010
3	Messenger RNA (mRNA)IBA 01/2016 - 10/2006
3	Imatinib Mesylate (Gleevec)FDA Link 08/2014 - 04/2011
2	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
2	afliberceptIBA 11/2023 - 07/2022
2	Trinitrotoluene (TNT)IBA 01/2023 - 11/2021
2	regorafenibIBA 01/2021 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2015
2	Cytostatic AgentsIBA 01/2020 - 01/2018
2	veliparibIBA 08/2019 - 01/2019
2	Doxycycline (Periostat)FDA LinkGeneric 01/2019 - 12/2017
2	VemurafenibIBA 12/2018 - 08/2015
2	Prostate-Specific Antigen (Semenogelase)IBA 03/2018 - 01/2017
2	cabazitaxel FDA Link 03/2018 - 01/2017
2	AntibodiesIBA 01/2017 - 11/2011
2	SodiumIBA 01/2017 - 04/2005
2	Proteins (Proteins, Gene)FDA Link 04/2016 - 10/2006
2	Gefitinib (Iressa)FDA Link 04/2016 - 12/2006
2	tyrosine receptor (receptor, tyrosine)IBA 01/2016 - 04/2011
2	Cisplatin (Platino)FDA LinkGeneric 06/2015 - 01/2009
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2013 - 12/2008
2	TransketolaseIBA 08/2011 - 10/2006
2	Transaminases (Aminotransferases)IBA 08/2009 - 06/2008
2	liposomal doxorubicin (Doxil)FDA Link 08/2005 - 04/2005
1	atezolizumabIBA 11/2023
1	B 43IBA 01/2023
1	pembrolizumabIBA 01/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023
1	A 19IBA 01/2023

Therapy/Procedure

32	Drug Therapy (Chemotherapy) 10/2023 - 03/2005
29	Therapeutics 04/2024 - 01/2005
20	Neoadjuvant Therapy 02/2024 - 03/2005
18	Chemoradiotherapy 01/2023 - 12/2008
11	Radiotherapy 03/2024 - 03/2005
7	Adjuvant Chemotherapy 01/2023 - 04/2015
3	Induction Chemotherapy 09/2020 - 05/2013
3	Palliative Care (Palliative Therapy) 01/2018 - 07/2009
3	capecitabine-irinotecan combination 08/2009 - 03/2005
2	Immunotherapy 04/2024 - 02/2024
2	Consolidation Chemotherapy 01/2022 - 12/2019
2	Stem Cell Transplantation 12/2021 - 01/2017
2	Castration 03/2018 - 01/2017
2	Duration of Therapy 12/2016 - 08/2015
1	Operative Surgical Procedures 03/2024
1	Integrative Oncology 10/2023
1	Aftercare (After-Treatment) 10/2023
1	Esophagectomy 01/2023
1	Brachytherapy 01/2023